WallStreetZenWallStreetZen

NASDAQ: DXCM
Dexcom Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Dexcom earnings were $836.3M for the trailing 12 months ending Dec 31, 2025, with 46.6% growth year over year. The latest DXCM earnings report on Dec 31, 2025 announced Q4 2025 earnings of $267.3M, down 5.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, DXCM reported annual earnings of $836.3M, with 45.1% growth. The next DXCM earnings date is Apr 23, 2026.

DXCM past earnings growth

How has DXCM's earnings growth performed historically?

Company
46.58%
Industry
23.26%
Market
86.37%
DXCM's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
DXCM's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
DXCM's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

DXCM earnings history

Current Revenue
$4.7B
Current Earnings
$836.3M
Current Profit Margin
17.9%

DXCM Return on Equity

Current Company
32.4%
Current Industry
9.3%
Current Market
29.5%
DXCM's Return on Equity (32.4%)... subscribe to Premium to read more.
High Return on Equity Performance

DXCM Return on Assets

Current Company
12%
Current Industry
5.7%
DXCM is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when DXCM announces earnings.

DXCM Return on Capital Employed

Current Company
26.37%
Current Industry
9.9%
DXCM has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

DXCM vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
DXCM$1.36B$836.30M+7.95%$2.14
PHG$3.12B$1.05BN/A-$0.88
STE$1.48B$707.87M+7.18%$7.20
ZBH$2.22B$705.10M+16.54%$3.56
PODD$489.30M$247.10M+99.89%$3.51
View Top Medical Device Stocks

DXCM earnings dates

Next earnings date
Apr 23, 2026

Dexcom Earnings Reports & History FAQ

What were Dexcom's earnings last quarter?

On DXCM's earnings call on Invalid Date, Dexcom (NASDAQ: DXCM) reported Q4 2025 earnings per share (EPS) of $0.69, up 81.58% year over year. Total DXCM earnings for the quarter were $267.30 million. In the same quarter last year, Dexcom's earnings per share (EPS) was $0.38.

If you're new to stock investing, here's how to buy Dexcom stock.

When does Dexcom report earnings?

The next DXCM earnings date is Invalid Date. Add DXCM to your watchlist to be reminded of Dexcom's next earnings date.

Is Dexcom profitable or losing money?

As of the last Dexcom earnings report, Dexcom is currently profitable. Dexcom's net profit (also called net income) for the twelve months ending Dec 31, 2025 was $836.30 million, a 45.14% increase year over year.

What was DXCM's earnings growth in the past year?

As of Dexcom's earnings date in Invalid Date, Dexcom's earnings has grown 46.58% year over year. This is 23.32 percentage points higher than the US Medical Devices industry earnings growth rate of 23.26%. DXCM earnings in the past year totalled $836.30 million.

What are Dexcom's earnings expectations?

The current EPS estimate for Dexcom's earnings report in Invalid Date is $0.47.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.